DaShenLin Pharmaceutical Group News

Dashenlin: Announcement by Dashenlin Pharmaceutical Group Co., Ltd. on interest payments on convertible corporate bonds in 2022

Oct 17, 2022 12:00 ET

Dashenlin: Report on the fiduciary management affairs of the public issuance of convertible corporate bonds by Dashenlin Pharmaceutical Group Co., Ltd. (2021)

Jun 29, 2022 12:00 ET

Dashenlin: 2020 Dashenlin Pharmaceutical Group Co., Ltd. Convertible Corporate Bonds 2022 Tracking Rating Report

Jun 22, 2022 12:00 ET

Dashenlin: Announcement by Dashenlin Pharmaceutical Group Co., Ltd. on the tracking rating results of convertible corporate bonds in 2022

Jun 22, 2022 12:00 ET

Dashenlin: Dashenlin Pharmaceutical Group Co., Ltd.'s 2021 Annual Equity Distribution Implementation Notice

Jun 6, 2022 12:00 ET

Dashanlin Pharmaceutical Group Co., Ltd.'s 2021 Annual Equity Distribution Implementation Notice

Jun 6, 2022 12:00 ET

Dashenlin: Announcement by Dashenlin Pharmaceutical Group Co., Ltd. on interest payments on convertible corporate bonds in 2021

Oct 17, 2021 12:00 ET

Dashenlin: Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the 2021 tracking credit rating report for convertible corporate bonds

Jun 16, 2021 12:00 ET

Dashenlin: 2020 Dashenlin Pharmaceutical Group Co., Ltd. Convertible Corporate Bonds 2021 Tracking Rating Report

Jun 16, 2021 12:00 ET

Dashenlin: Credit Rating Report on Pharmaceutical Group Co., Ltd.'s 2020 Public Offering of Convertible Corporate Bonds

Oct 19, 2020 12:00 ET

Dashenlin: Online roadshow announcement on the public offering of convertible corporate bonds by Pharmaceutical Group Co., Ltd.

Oct 19, 2020 12:00 ET

Da Shen Lin: Notice on the application for the public issuance of convertible corporate bonds being reviewed and approved by the Issuance Review Committee of the China Securities Regulatory Commission

Aug 17, 2020 12:00 ET

Da Shen Lin: Announcement on the acceptance of the application for the public issuance of convertible corporate bonds by the China Securities Regulatory Commission

Jun 8, 2020 12:00 ET

Da Shen Lin: Feasibility Analysis Report on the Use of Funds Raised by the Public Issuance of Convertible Corporate Bonds

Mar 19, 2020 12:00 ET

Da Shen Lin: Notice on diluting immediate returns on the public issuance of convertible corporate bonds and measures to fill them

Mar 19, 2020 12:00 ET

Dashenlin: A Plan for Public Issuance of Convertible Corporate Bonds

Mar 19, 2020 12:00 ET

Dashenlin: Convertible Corporate Bondholders' Meeting Rules (March 2020)

Mar 19, 2020 12:00 ET

Dashenlin: China Securities Pengyuan's announcement on the termination of the “2019 Dashenlin Pharmaceutical Group Co., Ltd. Convertible Corporate Bond Credit Rating”

Feb 14, 2020 11:00 ET

Dashenlin: Announcement on the “Shenlin Convertible Bonds” redemption results and stock changes

Jan 17, 2020 11:00 ET

Dashenlin: Fourth Prompt Announcement on Implementing the “Shenlin Convertible Bonds” Redemption

Jan 15, 2020 11:00 ET